Alzheimer’s Disease Studies

See If You May Qualify
(844) 427-4042

About Clinical Research

Understanding Clinical Research

Clinical research studies seek to advance and improve treatment options for a variety of conditions, including Alzheimer’s disease. They are designed to answer questions about the safety and effectiveness of potential new drugs and medicines.

Quick Facts

  • Clinical research studies must be performed before a new drug or treatment can be approved for use and made available to the public.
  • There are common characteristics that people must have to participate in a study, called eligibility criteria. Common criteria include age, current medicines, medical history, and other medical conditions.
  • Right now, there are more than 400,000 studies exploring a wide range of conditions in progress around the world.1
  • Many conditions affect diverse groups of people, so it is important to have diverse groups of people participating in research. Different people may respond differently to medicines.

Consider participating in an Alzheimer’s disease research study.

See If You May Qualify

Why Participate?

Taking part in a research study may offer several benefits, including:2
  • Getting actively involved in your own healthcare
  • Having access to investigational drugs
  • Helping others by progressing medical research
Taking part in a research study may also have risks, including:2
  • Having side effects caused by the investigational drug or study-specific procedures
  • Having no effect from the investigational drug
  • Being part of the research study group that doesn’t get the investigational drug

Always make sure to discuss potential benefits and risks of participation with your doctor.

Diversity & Inclusion in Clinical Research

Diverse representation in clinical research is critical—it helps our researchers ensure that we’re making medicines that will be as effective as possible for patients who use them. People respond differently to medicines depending on their age, sex, race, ethnicity, and many other factors.

Read More

Sources:
[1] https://clinicaltrials.gov/ct2/resources/trends
[2] nia.nih.gov/health/clinical-trials-benefits-risks-and-safety

These goals guide Lilly’s work:

Create a Robust Clinical Research Study Strategy and Reach Diverse Populations

Our teams aim for each study’s participants to match the composition of the U.S. patient population that might use that study’s drug if it’s approved. Across research studies globally, we identify and address barriers that keep underrepresented populations from participating.

Intentionally Select a Diverse Range of Sites and Investigators

We aim to recruit more research study investigators and external advisors who represent women and racial/ethnic minority populations, with the ultimate goal of having our investigators and advisors match the composition of the U.S. population in terms of gender and race/ethnicity.

Increase Diverse Representation through Partnerships and Collaborations

We collaborate with patients, patient advocacy groups, regulatory agencies, healthcare professionals, and community organizations to identify and implement solutions that will result in diverse representation, improve health equity, and generate evidence to support better patient results.

Close

Neurons

See how you’re staring at this image? When we stare, shout, walk, or remember, it’s the result of signals passing through the 100 billion nerve cells in our brain called neurons.

Electrical charges help these neurons talk to each other. These charges can generate enough electricity to power a low-wattage bulb!1 The combination of these electrical and chemical signals is responsible for the actions mentioned above.

Back to Infographic